PITTSBURGH, PA Precision Therapeutics, Inc. today announced that CEO Sean McDonald provided a company presentation at the J.P. Morgan 28th Annual Healthcare Conference, held at the Westin St. Francis Hotel in San Francisco, California, on Thursday, January 14, 2010. The presentation included a discussion of the company’s marketed products, its strategy for growth, and other matters relating to its business.
Precision Therapeutics, headquartered in Pittsburgh, Pennsylvania, is a life science company and leader in the development of innovative technology that delivers personalized diagnostics to physicians with the goal of supporting and optimizing difficult cancer therapy decisions (http://www.chemofx.com/
Precision’s ChemFx®, a proprietary drug response marker, measures an individual patient’s tumor response to various chemotherapeutic and biological agents prior to treating the patient. ChemoFx® can complement the physician’s experience and provide valuable patient-specific information, as there is typically not a uniform response to standard cancer treatment or no clear choice for the next regimen.
For more information:
http://www.precisiontherapeutics.com
http://www.chemofx.com
